Akèy › Kansè kol
Etid klinik pou Kansè kol ap rekrite nan Etazini
114 etid pou Kansè kol ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX34 etid
- New York City, NY19 etid
- Nashville, TN19 etid
- Boston, MA18 etid
- Arlington, VA16 etid
- Los Angeles, CA16 etid
- San Antonio, TX14 etid
- Dallas, TX13 etid
- St. Louis, MO13 etid
- Chicago, IL12 etid
- Orlando, FL12 etid
- Columbus, OH11 etid
- Baldwin Park, CA11 etid
- Atlanta, GA10 etid
- Cleveland, OH10 etid
- San Diego, CA10 etid
- Philadelphia, PA10 etid
- Edison, NJ10 etid
- Queens, NY10 etid
- Portland, OR9 etid
- Minneapolis, MN9 etid
- Durham, NC9 etid
- Miami, FL9 etid
- Washington, DC9 etid
- Birmingham, AL8 etid
- Baltimore, MD8 etid
- Jacksonville, FL7 etid
- New Orleans, LA7 etid
- Oklahoma City, OK7 etid
- Pittsburgh, PA7 etid
- Denver, CO7 etid
- Rochester, MN7 etid
- Seattle, WA7 etid
- Grand Rapids, MI6 etid
- Salt Lake City, UT6 etid
- Austin, TX6 etid
- Santa Monica, CA6 etid
- New Haven, CT6 etid
- Memphis, TN5 etid
- West Valley City, UT5 etid
Pa eta
- Alabama9 etid
- Arizona8 etid
- Arkansas3 etid
- Colorado12 etid
- Connecticut9 etid
- Distrik Columbia5 etid
- Florid29 etid
- Georgia14 etid
- Illinois15 etid
- Indiana5 etid
- Iowa5 etid
- Kalifòni38 etid
- Kansas3 etid
- Kentucky7 etid
- Lwizyàn8 etid
- Maryland12 etid
- Massachusetts19 etid
- Michigan14 etid
- Minnesota18 etid
- Mississippi3 etid
- Missouri13 etid
- Nebraska4 etid
- Nevada5 etid
- New Jersey13 etid
- New Mexico4 etid
- New York23 etid
- North Carolina14 etid
- Ohio24 etid
- Oklahoma11 etid
- Oregon10 etid
- Pennsylvania15 etid
- Rhode Island4 etid
- South Carolina6 etid
- Tennessee21 etid
- Texas45 etid
- Utah10 etid
- Virginia20 etid
- Washington10 etid
- West Virginia3 etid
- Wisconsin7 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Oct 1, 2026 · NCT07292818177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07189871A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05051722Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT06952660A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT07216703DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT06814496A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Sep 21, 2026 · NCT06925724Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT04038619A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07109726Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT05475171PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Sep 17, 2026 · NCT05758688GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04977453Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 14, 2026 · NCT04723095Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06535607Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Sep 10, 2026 · NCT04865887Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06465069A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06400472A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06760819Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.